• What fundamental changes have been noted over the past decade?
• What challenges exist that are harder to overcome? What are clear-cut and feasible opportunities for even the best partnership models?
• What is the outlook for the ways in which these partnerships will continue to evolve? What does this mean for stakeholders involved?
To listen to the podcast, visit http://www.healthtech.com/
Dr. Melese will be moderating a discussion on this topic during the 11th Annual Strategic Alliance Management Congress, taking place, May 5-7, 2014 in Philadelphia. She'll be joined by a notable panel of the industry's best, including Anthony Marshall of IBM, Sylvaine Cases of Sanofi-Aventis, Noah Leibowitz of Simpson Thacher & Bartlett, and Yvonne Tran of Schrödinger.
Learn more about the event at http://www.healthtech.com/
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.